Skip to main content
Home
  • About
    • About SGC
    • Member Funders
    • Governance
    • Open Science
    • Impact
  • SGC Sites & People
    • Global
    • SGC Toronto
    • SGC UNC
    • SGC Karolinska
    • SGC Frankfurt
    • SGC Neuro
    • SGC UCL
    • SGC Unicamp
  • Science and Resources
    • Proteins
      • Structure Gallery
      • Protein Production Resources
        • Expression Vectors
        • Constructs
    • Chemistry
      • Chemical Probes
        • SGC Chemical Probes
        • Donated Chemical Probes
        • Chemical Handles
      • Chemogenomic Sets
    • Open Data
    • Target Enabling Packages
    • Patient Tissue Platform
    • Open Lab Notebooks
    • Publications
    • Bioinformatics Resources
      • ChemBioPort
      • UbiHub
      • ChromoHub
  • Initiatives
    • Overview
      • Target 2035
      • Contribute your Proteins to Target 2035
      • AIRCHECK
      • MAINFRAME
      • CACHE
      • Conscience
      • Agora Open Science Trust
      • EUbOPEN
      • Open Chemistry Networks
      • Women’s and Children’s Health Initiative
      • READDI AViDD
      • TREAT AD
      • YCharOS
  • News & Outreach
    • News from SGC
    • Press Releases
    • Blogs
  • Get Involved
    • Participate
    • Donate
    • Careers
    • Contact Us
  • Home
  • About
    • About SGC
    • Member Funders
    • Governance
    • Open Science
    • Impact
  • SGC Sites & People
    • Global
    • SGC Toronto
    • SGC UNC
    • SGC Karolinska
    • SGC Frankfurt
    • SGC Neuro
    • SGC UCL
  • Science and Resources
    • Proteins
      • Structure Gallery
      • Protein Production Resources
        • Expression Vectors
        • Constructs
    • Chemistry
      • Chemical Probes
        • SGC Chemical Probes
        • Donated Chemical Probes
        • Chemical Handles
      • Chemogenomic Sets
        • EUbOPEN Chemogenomic Sets
        • KCGS
    • Open Data
    • Target Enabling Packages
    • Patient Tissue Platform
    • Open Lab Notebooks
    • Publications
    • Bioinformatics Resources
      • ChemBioPort
      • UbiHub
      • ChromoHub
  • Initiatives
    • Overview
      • Open Chemistry Networks
      • Target 2035
      • CACHE
      • Women’s and Children’s Health Initiative
      • Viral Medicines Initiative
      • READDI AViDD
      • Agora Open Science Trust
      • TREAT AD
      • EUbOPEN
      • YCharOS
  • News & Outreach
    • News from SGC
    • Press Releases
    • Blogs
  • Get Involved
    • Participate
    • Donate
    • Careers
    • Contact Us

LOTUS domain is a novel class of G-rich and G-quadruplex RNA binding domain.

  • Read more about LOTUS domain is a novel class of G-rich and G-quadruplex RNA binding domain.

Comparative structural analyses and nucleotide-binding characterization of the four KH domains of FUBP1.

  • Read more about Comparative structural analyses and nucleotide-binding characterization of the four KH domains of FUBP1.

Catalytic Domain Plasticity of MKK7 Reveals Structural Mechanisms of Allosteric Activation and Diverse Targeting Opportunities.

  • Read more about Catalytic Domain Plasticity of MKK7 Reveals Structural Mechanisms of Allosteric Activation and Diverse Targeting Opportunities.

DFG-1 residue controls inhibitor binding mode and affinity providing a basis for rational design of kinase inhibitor selectivity.

  • Read more about DFG-1 residue controls inhibitor binding mode and affinity providing a basis for rational design of kinase inhibitor selectivity.

Leveraging an Open Science Drug Discovery Model to Develop CNS Penetrant ALK2 Inhibitors for the Treatment of Diffuse Intrinsic Pontine Glioma.

  • Read more about Leveraging an Open Science Drug Discovery Model to Develop CNS Penetrant ALK2 Inhibitors for the Treatment of Diffuse Intrinsic Pontine Glioma.

A novel screening approach comparing kinase activity of small molecule inhibitors with similar molecular structures and distinct biologic effects in triple-negative breast cancer to identify targetable signaling pathways.

  • Read more about A novel screening approach comparing kinase activity of small molecule inhibitors with similar molecular structures and distinct biologic effects in triple-negative breast cancer to identify targetable signaling pathways.

Deliberately Losing Control of C-H Activation Processes in the Design of Small Molecule Fragment Arrays Targeting Peroxisomal Metabolism.

  • Read more about Deliberately Losing Control of C-H Activation Processes in the Design of Small Molecule Fragment Arrays Targeting Peroxisomal Metabolism.

Nucleotide Binding, Evolutionary Insights, and Interaction Partners of the Pseudokinase Unc-51-like Kinase 4.

  • Read more about Nucleotide Binding, Evolutionary Insights, and Interaction Partners of the Pseudokinase Unc-51-like Kinase 4.

Generation and validation of recombinant antibodies to study human aminoacyl tRNA synthetases.

  • Read more about Generation and validation of recombinant antibodies to study human aminoacyl tRNA synthetases.

GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer.

  • Read more about GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 148
  • Page 149
  • Page 150
  • Page 151
  • Current page 152
  • Page 153
  • Page 154
  • Page 155
  • Page 156
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

A global public-private partnership that supports the discovery of new medicines through open-access research.

  • Careers
  • Contact Us

Structural Genomics Consortium. Registered charity 04714553 (England and Wales). Registered company limited by guarantee 1097737 (England and Wales). Except where otherwise noted, all content on this site is licensed under a Creative Commons Attribution 4.0 International license (CC BY 4.0)

Be the first to know with our SGC Bulletin!

Want to know what we are up to?
Leave your e-mail address below and you will receive a monthly source of SGC news from across our six research sites.

SIGN UP FOR OUR NEWSLETTER

Footer

  • Privacy Policy
  • Legal Information
  • Accessbility
  • Contact Us
  • Login

Toronto website development by Rebel Trail